Physicians' Academy for Cardiovascular Education

Midlife cholesterol levels predict Alzheimer disease with ASCVD

Cardiovascular risk factors and glucose tolerance in midlife and risk of cognitive disorders in old age Up to a 49-year follow-up of the Helsinki Businessmen Study

Rantanen K, Strandberg AY., Salomaa VV, et al. - Ann Med. 2017 Feb 2:1-30


Primarily neurodegenerative as well as vascular processes contribute to dementia [1-3]. Most common diagnosis for progressing dementia is probable Alzheimer disease (AD). Long-term studies have strongly promoted the idea of AD as vascular state and consequently, sporadic late-onset AD is now considered a potentially preventable condition [4,5].

It is suggested that AD can be predicted by risk factors of atherosclerotic cardiovascular disease (ASCVD). Moreover, late-onset dementia, including AD, have been related to risk factors in midlife, such as high blood pressure (BP), hypercholesterolemia, obesity, physical inactivity, smoking, stroke and diabetes [1,6,7].

However, mixed results have been published regarding potential predictors, probably due to clinical variability of dementia in old age. This heterogeneity was reduced in the Helsinki Businessmen Study (HBS), by using a Finnish, initially healthy, same gender (men, Caucasian) and socioeconomically (highest strata) similar cohort (n=3309 used in the analyses), in which all were born between 1919-1934. The HBS study started in 1964 and investigated the relationship between ASCVD risk and glucose tolerance in midlife and dementia in old age over a period of 49 years in which 1911 deaths occurred.

Dementia types were well distinguished and patients were categorized into the following groups: ‘Pure AD’ (diagnosis of AD without any hint of ASCVD, n=93), AD-ASCVD (diagnosis of AD specified either as a cause of death or in the narrative, with any concomitant ASCVD, n=126), VD (diagnosis of vascular dementia [VD] specified as a cause of death or in the narrative, n=82), dementia or memory disorder mentioned in the death certificate but not as a specific diagnosis (n=27), Lewy body disease (LBD) with or without sign of other types of dementia (n=14), other specific diagnosis for dementia or memory disorder (n=8). Only the 3 largest groups were used for further analyses.

Main results


In this study with a long-term follow-up, pure AD (without ASCVD) was not associated with cholesterol levels, blood pressure, glucose tolerance of diabetes, whereas AD with ASCVD was significantly associated with midlife cholesterol levels.


Show references

Find this article online at Ann Med